Accepted Manuscript Chronic administration of nano-sized PAMAM dendrimers in vivo inhibits EGFR-ERK1/2-ROCK signaling pathway and attenuate diabetes-induced vascular remodeling and dysfunction Saghir Akhtar, Bindu Chandrasekhar, Mariam HM Yousif, Waleed Renno, Ibrahim F. Benter, Ahmed Z El-Hashim PII: S1549-9634(19)30043-7 DOI: https://doi.org/10.1016/j.nano.2019.02.012 Reference: NANO 1963 To appear in: Nanomedicine: Nanotechnology, Biology, and Medicine Revised date: 11 February 2019 Please cite this article as: S. Akhtar, B. Chandrasekhar, M.H. Yousif, et al., Chronic administration of nano-sized PAMAM dendrimers in vivo inhibits EGFR-ERK1/2-ROCK signaling pathway and attenuate diabetes-induced vascular remodeling and dysfunction, Nanomedicine: Nanotechnology, Biology, and Medicine, https://doi.org/10.1016/ j.nano.2019.02.012 This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.